Emergent BioSolutions ( NYSE:EBS ) Third Quarter 2024 Results Key Financial Results Revenue: US$293.8m (up 8.6% from 3Q... Emergent BioSolutions Inc (EBS) reports a robust financial performance ...

On Monday, Emergent Biosolutions Inc (EBS) stock saw a modest uptick, ending the day at $8.6 which represents a slight increase of $0.88 or 11.40% from the prior close of $7.72. The stock opened at $8 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

CME Group, the world's leading derivatives marketplace, today announced that its suite of Adjusted Interest Rate (AIR) Total Return futures reached an open interest (OI) record of 710,358 contracts ...

The U.S. Army is rolling out its latest and greatest business system modernization program: the Enterprise Business Systems – Convergence (EBS-C). Think of it as a corporate makeover show ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.93% of ...